Dr. Anas Hamdi, MD

Dr. Hamdi practices at Ccare in Nashville, Tennessee.

Dr. Hamdi's NPI, 1588185482, was assigned on June 29, 2017. Dr. Hamdi graduated from LSU Health Shreveport School of Medicine in 2017. Dr. Hamdi holds California license A176478.

Dr. Hamdi's primary practice is Ccare, at 104 Woodmont Blvd, Nashville, TN 37205 in Davidson County. The practice phone is (559) 326-1222.

Dr. Hamdi's primary practice is Ccare in Nashville, Tennessee. Dr. Hamdi is also affiliated with Community Regional Medical Center. The medical group on file is California Cancer Associates for Research and Excellence (cCARE). Dmand AI also links Dr. Hamdi to 2 more hospitals, 4 group practices and clinics, 3 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamdi practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Hamdi's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Hamdi is board certified in urology by the American Board of Urology. Dr. Hamdi is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Hamdi treats.

CMS data shows 3,647 Medicare services from Dr. Hamdi across 22 procedure codes in 2024, for 438 Medicare patients. Medicare paid $128,914 for them.

CMS counts 438 Medicare patients who saw Dr. Hamdi in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hamdi's median patient age at 65, with 46% women.

In 2024, Dr. Hamdi wrote 901 Medicare Part D claims for 384 patients. 82% of them were for generic drugs. CMS names the drug for 753 of them, across 16 drugs with 11 or more claims each, at $136,774 in total drug cost. In 2023, CMS named 634 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Hamdi for performance year 2024, reported as part of a group. Dr. Hamdi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hamdi as offering telehealth. CMS counts 21 procedures of prostate resection by Dr. Hamdi, more than 83% of the clinicians it reports for that procedure.

CMS Open Payments shows 175 general payments to Dr. Hamdi from 31 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 58% of the total. Boston Scientific Corporation paid the most, $2,039.

Dr. Hamdi graduated from LSU Health Shreveport School of Medicine in 2017.

Dr. Hamdi is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.